OrbusNeich Medical Group Holdings Limited (06929.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 3.70

From 52W high−23.19%

Volume38500.00

Market capHKD 3.15B

P/E (TTM)9.1x

P/S (TTM)2.1x

Div yield7.06%

Key dataSep 18, 2026

Open

HKD 3.70

From 52W high

−23.19%

Volume

38500.00

Market cap

HKD 3.15B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

4.2x

P/E (TTM)

9.1x

RSI (14)

49.3

MomentumView details →

1D Return

+4.08%

YTD Return

+5.66%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

9.1x

EV/EBITDA

4.2x

EV/Sales

1.1x

P/S (TTM)

2.1x

P/B (TTM)

1.0x

ProfitabilityView details →

Gross Margin

68.60%

Net Margin

22.33%

EBITDA Margin

25.75%

ROE (TTM)

10.43%

ROA (TTM)

9.49%

Asset Turnover

0.43x

GrowthView details →

Revenue YoY

+15.79%

EPS YoY

+8.50%

FCF YoY

+59.62%

Revenue CAGR 3Y

+9.67%

EPS CAGR 3Y

+17.10%

EBITDA YoY

+36.94%

MomentumView details →

1D Return

+4.08%

YTD Return

+5.66%

1Y Return

−11.46%

RSI (14)

49.3

vs 50D SMA

+0.68%

vs 200D SMA

−0.63%

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

10.07x

Quick Ratio

8.18x

Div Yield

7.06%

Div Rate

HKD 0.20

Div Growth 1Y

−20.00%

EarningsView details →

EPS (Actual)

HKD 0.20

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

0.28%

Financials snapshotView financials →

Revenue (TTM)

364.11M

Net Income (TTM)

84.31M

Op. CF (TTM)

119.08M

Next earningsMar 11, 2027 →

Latest newsMore news →

OrbusNeich Medical announced that executive director Liu Guizhen was appointed co-CEO effective August 17, 2026, alongside Qian Yongxun, and stepped down as COO; executive director Chen Yongcheng was appointed COO and stepped down as CFO and company secretary; Chen Wenying was appointed CFO and company secretary.34d ago

OrbusNeich Medical Group Holdings Limited announced plans to establish a new manufacturing facility in Indonesia to cater to local demand.38d ago

Similar companies

康德莱603987.SH 维力医疗603309.SH AtriCure, Inc.ATRC Warby Parker Inc.WRBY 奥泰生物688606.SH 拱东医疗605369.SH Find similar companies →

Latest newsMore news →

OrbusNeich Medical announced that executive director Liu Guizhen was appointed co-CEO effective August 17, 2026, alongside Qian Yongxun, and stepped down as COO; executive director Chen Yongcheng was appointed COO and stepped down as CFO and company secretary; Chen Wenying was appointed CFO and company secretary.34d ago OrbusNeich Medical Group Holdings Limited announced plans to establish a new manufacturing facility in Indonesia to cater to local demand.38d ago